ArticleOrphanet journal of rare diseases2021

Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression.

David Adams et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.